PCV29 ESTIMATING THE BUDGET IMPACT OF DABIGATRAN ETEXILATE IN THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWINGTOTAL HIP OR KNEE REPLACEMENT SURGERY- AN INTERACTIVE MODEL FOR LOCAL HEALTH ECONOMIES IN THE UK
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66327-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)66327-9/fulltext
Title :
PCV29 ESTIMATING THE BUDGET IMPACT OF DABIGATRAN ETEXILATE IN THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWINGTOTAL HIP OR KNEE REPLACEMENT SURGERY- AN INTERACTIVE MODEL FOR LOCAL HEALTH ECONOMIES IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66327-9&doi=10.1016/S1098-3015(10)66327-9
First page :
Section Title :
Open access? :
No
Section Order :
162